sulforaphane has been researched along with pyrazines in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Fei, P; Kong, AN; Matwyshyn, GA; Rushmore, TH | 1 |
Guillouzo, A; Langouët, S; Mahéo, K; Morel, F | 1 |
Furge, LL; Guengerich, FP; Guillouzo, A; Kerriguy, N; Langouët, S; Nakamura, K | 1 |
Chun, JA; Furge, LL; Haab, BB; Haddad, R; Klenow, S; Konwinski, RR; Larson, SC | 1 |
Delude, RL; Englert, JA; Fink, MP; Han, Y; Kellum, JA; Killeen, ME; Song, M; Stolz, DB | 1 |
Kensler, TW; Yates, MS | 1 |
Ebert, B; Kisiela, M; Maser, E; Wsól, V | 1 |
Koushki, D; Latifi, S; Matin, M; Norouzi Javidan, A | 1 |
Ali, M; Bonay, M; Deramaudt, TB; Vanhee, V; Vinit, S | 1 |
3 review(s) available for sulforaphane and pyrazines
Article | Year |
---|---|
The use of primary hepatocyte cultures for the evaluation of chemoprotective agents.
Topics: Animals; Anticarcinogenic Agents; Carcinogenicity Tests; Cells, Cultured; Humans; Isothiocyanates; Liver; Pyrazines; Rats; Sulfoxides; Thiocyanates; Thiones; Thiophenes; Toxicity Tests | 1997 |
Keap1 eye on the target: chemoprevention of liver cancer.
Topics: Aflatoxins; Animals; Anticarcinogenic Agents; Antioxidants; Carcinoma, Hepatocellular; Clinical Trials as Topic; Humans; Intracellular Signaling Peptides and Proteins; Isothiocyanates; Kelch-Like ECH-Associated Protein 1; Liver Neoplasms; NF-E2-Related Factor 2; Phenols; Pyrazines; Signal Transduction; Sulfoxides; Thiocyanates; Thiones; Thiophenes; Triterpenes | 2007 |
Efficacy of some non-conventional herbal medications (sulforaphane, tanshinone IIA, and tetramethylpyrazine) in inducing neuroprotection in comparison with interleukin-10 after spinal cord injury: A meta-analysis.
Topics: Abietanes; Herbal Medicine; Humans; Interleukin-10; Isothiocyanates; Neuroprotective Agents; Pyrazines; Spinal Cord Injuries; Sulfoxides | 2015 |
6 other study(ies) available for sulforaphane and pyrazines
Article | Year |
---|---|
Transcription regulation of rat glutathione S-transferase Ya subunit gene expression by chemopreventive agents.
Topics: Anticarcinogenic Agents; Blotting, Northern; Chloramphenicol O-Acetyltransferase; Dose-Response Relationship, Drug; Enzyme Induction; Gene Expression Regulation; Genes, Reporter; Glutathione Transferase; Humans; Isothiocyanates; Liver; Pyrazines; Sulfoxides; Tamoxifen; Thiocyanates; Thiones; Thiophenes; Time Factors; Transcription, Genetic; Transcriptional Activation; Tumor Cells, Cultured | 1996 |
Inhibition of human cytochrome P450 enzymes by 1,2-dithiole-3-thione, oltipraz and its derivatives, and sulforaphane.
Topics: Anticarcinogenic Agents; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Humans; Isothiocyanates; Pyrazines; Quinolines; Sulfoxides; Thiocyanates; Thiones; Thiophenes | 2000 |
Oltipraz, 3H-1,2-dithiole-3-thione, and sulforaphane induce overlapping and protective antioxidant responses in murine microglial cells.
Topics: Animals; Antioxidants; Blotting, Western; Cell Line; Cells, Cultured; DNA, Complementary; Hydrogen Peroxide; Isothiocyanates; Lipopolysaccharides; Mice; Microglia; Microscopy, Fluorescence; Oligonucleotide Array Sequence Analysis; Oxidants; Oxidative Stress; Pyrazines; Reactive Oxygen Species; RNA; Stimulation, Chemical; Sulfoxides; Thiocyanates; Thiones; Thiophenes | 2004 |
The phase 2 enzyme inducers ethacrynic acid, DL-sulforaphane, and oltipraz inhibit lipopolysaccharide-induced high-mobility group box 1 secretion by RAW 264.7 cells.
Topics: Active Transport, Cell Nucleus; Animals; Cells, Cultured; DNA; Enzyme Induction; Ethacrynic Acid; Extracellular Signal-Regulated MAP Kinases; HMGB1 Protein; Interleukin-10; Interleukin-6; Isothiocyanates; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Nitric Oxide; Phosphorylation; Pyrazines; Sulfoxides; Thiocyanates; Thiones; Thiophenes; Tumor Necrosis Factor-alpha | 2006 |
Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29.
Topics: 20-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductase Family 1 Member C3; Aldo-Keto Reductases; Boronic Acids; Bortezomib; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Induction; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Hydroxyprostaglandin Dehydrogenases; Isothiocyanates; Leupeptins; Maleates; Multidrug Resistance-Associated Protein 2; NF-E2-Related Factor 2; Protease Inhibitors; Proteasome Inhibitors; Pyrazines; RNA, Messenger; Sulfoxides; Thiocyanates; Time Factors | 2011 |
Comparative effectiveness of 4 natural and chemical activators of Nrf2 on inflammation, oxidative stress, macrophage polarization, and bactericidal activity in an in vitro macrophage infection model.
Topics: Anti-Inflammatory Agents; Antioxidants; Dimethyl Fumarate; Escherichia coli; Escherichia coli Infections; Flavanones; Humans; Inflammation; Isothiocyanates; Leukocytes, Mononuclear; Macrophage Activation; Macrophages; NF-E2-Related Factor 2; Oxidative Stress; Pyrazines; Staphylococcal Infections; Staphylococcus aureus; Sulfoxides; Thiones; Thiophenes; THP-1 Cells | 2020 |